New agonistic antibody reduced the amyloid pathology in mice with Alzheimer's disease
A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer's disease, signaling its promise as a potential treatment for the disease, according to a team of researchers at UTHealth Houston.
Source: news-medical.net